Literature DB >> 25315121

[Endoprosthetic treatment of the ankle].

J Götz1, J Grifka, H R Springorum, S May, C Baier.   

Abstract

BACKGROUND: Chronic polyarthritis is the second most common cause regarding the etiology of upper ankle osteoarthritis after posttraumatic degenerative changes. Patient mobility is limited by this painful disease. Besides conservative treatment options, replacement of the upper ankle joint is an operative therapeutic option in eligible candidates which provides very good results.
OBJECTIVES: Besides epidemiological data, clinic presentation, diagnostic tools, treatment options and management of postoperative complications for patients with ankle osteoarthritis, this article presents the results of midterm outcome after total ankle replacement.
MATERIAL AND METHODS: The retrospective results of 44 patients after total ankle arthroplasty are presented.
RESULTS: After an average follow-up of 53 months (range 20-98 months) the majority of results were good or excellent with respect to pain relief.
CONCLUSION: Total ankle replacement is a good option for treating osteoarthritis of the ankle joint in rheumatoid arthritis when attention is paid to the eligibility of the patients.

Entities:  

Mesh:

Year:  2014        PMID: 25315121     DOI: 10.1007/s00393-014-1404-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  15 in total

Review 1.  Long-term outcome of ankle arthrodesis.

Authors:  Dawson C Muir; Annunziato Amendola; Charles L Saltzman
Journal:  Foot Ankle Clin       Date:  2002-12       Impact factor: 1.653

Review 2.  [Total ankle replacement in rheumatoid arthritis].

Authors:  P F Rippstein; F D Naal
Journal:  Orthopade       Date:  2011-11       Impact factor: 1.087

3.  Impact of complications in total ankle replacement and ankle arthrodesis analyzed with a validated outcome measurement.

Authors:  Fabian G Krause; Markus Windolf; Biraj Bora; Murray J Penner; Kevin J Wing; Alastair S E Younger
Journal:  J Bone Joint Surg Am       Date:  2011-04-15       Impact factor: 5.284

4.  The Scandinavian total ankle replacement: long-term, eleven to fifteen-year, survivorship analysis of the prosthesis in seventy-two consecutive patients.

Authors:  Samuel Brunner; Alexej Barg; Markus Knupp; Lukas Zwicky; Ashley L Kapron; Victor Valderrabano; Beat Hintermann
Journal:  J Bone Joint Surg Am       Date:  2013-04-17       Impact factor: 5.284

5.  Epidemiology of ankle arthritis: report of a consecutive series of 639 patients from a tertiary orthopaedic center.

Authors:  Charles L Saltzman; Michael L Salamon; G Michael Blanchard; Thomas Huff; Andrea Hayes; Joseph A Buckwalter; Annunziato Amendola
Journal:  Iowa Orthop J       Date:  2005

Review 6.  Results of total ankle arthroplasty.

Authors:  Mark E Easley; Samuel B Adams; W Chad Hembree; James K DeOrio
Journal:  J Bone Joint Surg Am       Date:  2011-08-03       Impact factor: 5.284

7.  Long-term results following ankle arthrodesis for post-traumatic arthritis.

Authors:  L M Coester; C L Saltzman; J Leupold; W Pontarelli
Journal:  J Bone Joint Surg Am       Date:  2001-02       Impact factor: 5.284

8.  Impact of comorbidities on the measurement of health in patients with ankle osteoarthritis.

Authors:  Charles L Saltzman; M Bridget Zimmerman; Michael O'Rourke; Thomas D Brown; Joseph A Buckwalter; Richard Johnston
Journal:  J Bone Joint Surg Am       Date:  2006-11       Impact factor: 5.284

9.  Complications and long-term results of ankle arthrodeses following trauma.

Authors:  B F Morrey; G P Wiedeman
Journal:  J Bone Joint Surg Am       Date:  1980-07       Impact factor: 5.284

10.  Treatment of ankle osteoarthritis: arthrodesis versus total ankle replacement.

Authors:  N Espinosa; G Klammer
Journal:  Eur J Trauma Emerg Surg       Date:  2010-11-13       Impact factor: 3.693

View more
  1 in total

1.  [Hindfoot deformities in adults. Conservative and surgical treatment].

Authors:  J Götz; J Grifka; C Baier
Journal:  Orthopade       Date:  2016-01       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.